research Fluridil, a Rationally Designed Topical Agent for Androgenetic Alopecia
Fluridil safely promotes hair growth in men with androgenetic alopecia.
Search
for
Sort by
Research
660-690 / 1000+ results 
research Reversible Anagen Effluvium Induced by Azathioprine: A Rare Adverse Effect Case Report
Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.
research Hemoglobin, ferritin and thyroid profile in women with chronic telogen effluvium
Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.
research Role of ferritin, vitamin D, and thyroid dysfunction in telogen effluvium among the hospital population in Western Saudi Arabia: a case–control study
Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.
research Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function
The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.
research 160 Selected psychological stress and cognitive function parameters in patients suffering from COVID-19 induced telogen effluvium
COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.
research At a glance: Alopecia areata vs telogen effluvium, and seborrhoeis dermatitis vs scalp psoriasis
Different scalp conditions have distinct features and causes.
research ALOPECIA ANDROGENÉTICA FEMININA: UMA REVISÃO DE LITERATURA
Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.
research Prevalence and factors associated with telogen effluvium in adult females at Makkah region, Saudi Arabia: A retrospective study
Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.
research Efficacy of Compound GV-350 with Tricofer® Iron, Cystine and Biotin in the Management of Telogen Effluvium in Women with Iron Deficiency
GV-350 improves hair growth and quality of life in iron-deficient women without side effects.
research Tratamiento con Exosomas en Alopecia Areata Difusa Refractaria en Paciente Pediátrico: Reporte de Caso
Exosomes helped regrow hair in a 14-year-old with difficult-to-treat alopecia.
research Clinical and Histopathological Features of Hair Loss in 17 Japanese Patients With Hematologic Disorders Following Hematopoietic Stem Cell Transplantation and Chemotherapy: A Case Series.
Hair miniaturization is the main cause of long-term hair loss after stem cell transplantation and chemotherapy, and treatments like topical minoxidil can help improve hair volume.
research Male pattern hair loss - rh79g
research The Proportion of Catagen and Telogen Hair Follicles in Occipital Scalp of Male Androgenetic Alopecia Patients: Challenging the Established Dogma
The belief about hair shedding phases is likely incorrect and needs reevaluation.
research 675-nm diode laser as an adjuvant treatment for telogen effluvium: case series
The 675-nm diode laser may safely help treat telogen effluvium.
research Alopecia and COVID-19: possible etiopathogenetic variants and therapeutic approach
COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.
research Evaluating the effectiveness of Wiesbaden 30ch versus supportive haircare in reducing telogen effluvium: A comparative study
Wiesbaden 30CH is more effective than supportive haircare for improving telogen effluvium.
research A case of imiquimod-induced alopecia
Imiquimod cream can rarely cause temporary hair loss.
research Hirsutism, postpartum telogen effluvium, and male pattern alopecia
Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.
research Iron deficiency and hair loss—Nothing new?
Iron deficiency might be linked to hair loss, but more research is needed.
research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.
research A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.
research Characteristics of hair loss after COVID‐19: A systematic scoping review
COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.
research Perda pilosa por líquen plano pilar após transplante capilar: relato de dois casos e revisão da literatura
Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.
research Alopecia Associated with Fluconazole Therapy
High doses of fluconazole can cause reversible hair loss.
research Morphogenesis of the hair follicle during catagen
research Fixed focal alopecia for 20 years
The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.
research Serum vitamin D, ferritin, and TSH in patients with telogen effluvium: a retrospective epidemiological study
Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.
research Fluridil, a Rationally Designed Topical Agent for Androgenetic Alopecia: First Clinical Experience
Fluridil safely promotes hair growth in men with androgenetic alopecia.
research Thyroid peroxidase antibodies in patients with telogen effluvium
Some people with chronic hair loss may have thyroid autoimmunity.